Identification of Ki (Ku, p70/p80) autoantigens and analysis of anti-Ki autoantibody reactivity
- PMID: 2419410
Identification of Ki (Ku, p70/p80) autoantigens and analysis of anti-Ki autoantibody reactivity
Abstract
Anti-Ki (Ku, p70/p80) autoantibodies, named after the prototype patient Kikuta by Tojo et al., occur in approximately 10% of patients with SLE, often in association with anti-Sm autoantibodies. The immunofluorescent staining pattern characteristic of anti-Ki antibodies is diffuse speckled nuclear, although some substrates show nucleolar staining as well. Anti-Ki sera specifically immunoprecipitated two protein antigens, Ki86 (Mr 86,000) and Ki66 (Mr 66,000), from radiolabeled cell extracts. The Ki system was found to be immunologically identical to the Ku system described by Mimori et al. and the p70/p80 system described by Reeves. The Ki primary in vitro translation products were identified and proved similar in size to the cellular antigens. The Ki antigens were purified from human spleen by immunoaffinity chromatography followed by SDS-PAGE. The purified Ki antigens proved to be closely related by amino acid composition, and did not appear to be phosphorylated, glycosylated, or associated with RNA. The Ki antigens were found to bind to DNA, in agreement with the observations on the Ku and p70/p80 antigens. They were found to be widely conserved in mammals and were coordinately expressed in all tissues tested. Anti-Ki autoantibodies were purified by antigen-affinity chromatography and were tested by immunoblotting. The antibodies were classified as class I, II, or III, depending on their reactivity with the Ki antigens in immunoblots. Class I antibodies cross-reacted with both Ki antigens, class II antibodies reacted solely with Ki66, and class III antibodies reacted solely with Ki86. These results suggest that at least three different epitopes are present on the Ki autoantigens and that patients differ in their autoantibody response to each epitope.
Similar articles
-
Epitopes of the p70 and p80 (Ku) lupus autoantigens.J Immunol. 1991 Apr 15;146(8):2678-86. J Immunol. 1991. PMID: 1707916
-
Human autoantibodies stabilize the quaternary structure of Ku antigen.Arthritis Rheum. 1997 Jul;40(7):1344-53. doi: 10.1002/1529-0131(199707)40:7<1344::AID-ART20>3.0.CO;2-V. Arthritis Rheum. 1997. PMID: 9214436
-
Role of antigen selectivity in autoimmune responses to the Ku (p70/p80) antigen.J Clin Invest. 1989 Aug;84(2):562-7. doi: 10.1172/JCI114199. J Clin Invest. 1989. PMID: 2527251 Free PMC article.
-
Antibodies to the p70/p80 (Ku) antigens in systemic lupus erythematosus.Rheum Dis Clin North Am. 1992 May;18(2):391-414. Rheum Dis Clin North Am. 1992. PMID: 1626075 Review.
-
Epitope mapping of autoantigens using recombinant proteins and synthetic peptides.Clin Exp Rheumatol. 1989 Sep-Oct;7 Suppl 3:S63-8. Clin Exp Rheumatol. 1989. PMID: 2481579 Review.
Cited by
-
Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease.J Clin Invest. 1995 Mar;95(3):1316-27. doi: 10.1172/JCI117782. J Clin Invest. 1995. PMID: 7533789 Free PMC article.
-
p70 lupus autoantigen binds the enhancer of the T-cell receptor beta-chain gene.Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2685-9. doi: 10.1073/pnas.90.7.2685. Proc Natl Acad Sci U S A. 1993. PMID: 8464876 Free PMC article.
-
Saccharomyces cerevisiae Ku70 potentiates illegitimate DNA double-strand break repair and serves as a barrier to error-prone DNA repair pathways.EMBO J. 1996 Sep 16;15(18):5093-103. EMBO J. 1996. PMID: 8890183 Free PMC article.
-
Systemic sclerosis associated myopathy: how to treat.Curr Treatm Opt Rheumatol. 2023 Dec;9(4):151-167. doi: 10.1007/s40674-023-00206-y. Epub 2023 Jul 19. Curr Treatm Opt Rheumatol. 2023. PMID: 38737329 Free PMC article.
-
Interaction of Ku protein and DNA-dependent protein kinase catalytic subunit with nucleic acids.Nucleic Acids Res. 1998 Apr 1;26(7):1551-9. doi: 10.1093/nar/26.7.1551. Nucleic Acids Res. 1998. PMID: 9512523 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources